Days alive and out of hospital after video-assisted thoracoscopic surgery wedge resection in the era of enhanced recovery

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Days alive and out of hospital after video-assisted thoracoscopic surgery wedge resection in the era of enhanced recovery. / Huang, Lin; Frandsen, Mikkel Nicklas; Kehlet, Henrik; Petersen, René Horsleben.

In: BJS open, Vol. 7, No. 6, zrad144, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Huang, L, Frandsen, MN, Kehlet, H & Petersen, RH 2023, 'Days alive and out of hospital after video-assisted thoracoscopic surgery wedge resection in the era of enhanced recovery', BJS open, vol. 7, no. 6, zrad144. https://doi.org/10.1093/bjsopen/zrad144

APA

Huang, L., Frandsen, M. N., Kehlet, H., & Petersen, R. H. (2023). Days alive and out of hospital after video-assisted thoracoscopic surgery wedge resection in the era of enhanced recovery. BJS open, 7(6), [zrad144]. https://doi.org/10.1093/bjsopen/zrad144

Vancouver

Huang L, Frandsen MN, Kehlet H, Petersen RH. Days alive and out of hospital after video-assisted thoracoscopic surgery wedge resection in the era of enhanced recovery. BJS open. 2023;7(6). zrad144. https://doi.org/10.1093/bjsopen/zrad144

Author

Huang, Lin ; Frandsen, Mikkel Nicklas ; Kehlet, Henrik ; Petersen, René Horsleben. / Days alive and out of hospital after video-assisted thoracoscopic surgery wedge resection in the era of enhanced recovery. In: BJS open. 2023 ; Vol. 7, No. 6.

Bibtex

@article{0e580359ceda47d5a7616812c0369836,
title = "Days alive and out of hospital after video-assisted thoracoscopic surgery wedge resection in the era of enhanced recovery",
abstract = "Background: Days alive and out of hospital is proposed as a valid and patient-centred quality measure for perioperative care. However, no procedure-specific data exist after pulmonary wedge resection. The aim of this study was to assess the first 90 days alive and out of hospital after video-assisted thoracoscopic surgery wedge resection in an optimized enhanced recovery programme. Methods: A retrospective analysis of prospectively collected data of consecutive patients undergoing enhanced recovery thoracoscopic wedge resections from January 2021 to June 2022 in a high-volume centre was carried out. All factors leading to hospitalization, readmission, and death were evaluated individually. A logistic regression model was used to evaluate predictors. Additionally, a sensitivity analysis was performed. Results: A total of 433 patients were included (21.7% (n = 94) with non-small cell lung cancer, 47.6% (n = 206) with metastasis, 26.8% (n = 116) with benign nodules, and 3.9% (n = 17) with other lung cancers). The median duration of hospital stay was 1 day. The median of postoperative 30 and 90 days alive and out of hospital was 28 and 88 days respectively. Air leak (112 patients) and pain (96 patients) were the most frequent reasons for reduced days alive and out of hospital from postoperative day 1 to 30, whereas treatment of the original cancer or metastasis (36 patients) was the most frequent reason for reduced days alive and out of hospital from postoperative day 31 to 90. Male sex, reduced lung function, longer dimension of resection margin, pleural adhesions, and non-small cell lung cancer were independent risks, confirmed by a sensitivity analysis. Conclusion: Days alive and out of hospital within 90 days after enhanced recovery thoracoscopic wedge resection was only reduced by a median of 2 days, mainly due to air leak and pain.",
author = "Lin Huang and Frandsen, {Mikkel Nicklas} and Henrik Kehlet and Petersen, {Ren{\'e} Horsleben}",
note = "Funding Information: This study was funded by a postdoctoral grant from Rigshospitalet (FF22opdt.020522, L.H.), a grant from the Novo Nordisk Foundation (R.H.P.), and a grant from Overl{\ae}ge Dr.med. Edgar Schnohr og hustru Gilberte Schnohr{\textquoteright}s Foundation (M.N.F.). Publisher Copyright: {\textcopyright} The Author(s) 2023.",
year = "2023",
doi = "10.1093/bjsopen/zrad144",
language = "English",
volume = "7",
journal = "BJS open",
issn = "2474-9842",
publisher = "Wiley",
number = "6",

}

RIS

TY - JOUR

T1 - Days alive and out of hospital after video-assisted thoracoscopic surgery wedge resection in the era of enhanced recovery

AU - Huang, Lin

AU - Frandsen, Mikkel Nicklas

AU - Kehlet, Henrik

AU - Petersen, René Horsleben

N1 - Funding Information: This study was funded by a postdoctoral grant from Rigshospitalet (FF22opdt.020522, L.H.), a grant from the Novo Nordisk Foundation (R.H.P.), and a grant from Overlæge Dr.med. Edgar Schnohr og hustru Gilberte Schnohr’s Foundation (M.N.F.). Publisher Copyright: © The Author(s) 2023.

PY - 2023

Y1 - 2023

N2 - Background: Days alive and out of hospital is proposed as a valid and patient-centred quality measure for perioperative care. However, no procedure-specific data exist after pulmonary wedge resection. The aim of this study was to assess the first 90 days alive and out of hospital after video-assisted thoracoscopic surgery wedge resection in an optimized enhanced recovery programme. Methods: A retrospective analysis of prospectively collected data of consecutive patients undergoing enhanced recovery thoracoscopic wedge resections from January 2021 to June 2022 in a high-volume centre was carried out. All factors leading to hospitalization, readmission, and death were evaluated individually. A logistic regression model was used to evaluate predictors. Additionally, a sensitivity analysis was performed. Results: A total of 433 patients were included (21.7% (n = 94) with non-small cell lung cancer, 47.6% (n = 206) with metastasis, 26.8% (n = 116) with benign nodules, and 3.9% (n = 17) with other lung cancers). The median duration of hospital stay was 1 day. The median of postoperative 30 and 90 days alive and out of hospital was 28 and 88 days respectively. Air leak (112 patients) and pain (96 patients) were the most frequent reasons for reduced days alive and out of hospital from postoperative day 1 to 30, whereas treatment of the original cancer or metastasis (36 patients) was the most frequent reason for reduced days alive and out of hospital from postoperative day 31 to 90. Male sex, reduced lung function, longer dimension of resection margin, pleural adhesions, and non-small cell lung cancer were independent risks, confirmed by a sensitivity analysis. Conclusion: Days alive and out of hospital within 90 days after enhanced recovery thoracoscopic wedge resection was only reduced by a median of 2 days, mainly due to air leak and pain.

AB - Background: Days alive and out of hospital is proposed as a valid and patient-centred quality measure for perioperative care. However, no procedure-specific data exist after pulmonary wedge resection. The aim of this study was to assess the first 90 days alive and out of hospital after video-assisted thoracoscopic surgery wedge resection in an optimized enhanced recovery programme. Methods: A retrospective analysis of prospectively collected data of consecutive patients undergoing enhanced recovery thoracoscopic wedge resections from January 2021 to June 2022 in a high-volume centre was carried out. All factors leading to hospitalization, readmission, and death were evaluated individually. A logistic regression model was used to evaluate predictors. Additionally, a sensitivity analysis was performed. Results: A total of 433 patients were included (21.7% (n = 94) with non-small cell lung cancer, 47.6% (n = 206) with metastasis, 26.8% (n = 116) with benign nodules, and 3.9% (n = 17) with other lung cancers). The median duration of hospital stay was 1 day. The median of postoperative 30 and 90 days alive and out of hospital was 28 and 88 days respectively. Air leak (112 patients) and pain (96 patients) were the most frequent reasons for reduced days alive and out of hospital from postoperative day 1 to 30, whereas treatment of the original cancer or metastasis (36 patients) was the most frequent reason for reduced days alive and out of hospital from postoperative day 31 to 90. Male sex, reduced lung function, longer dimension of resection margin, pleural adhesions, and non-small cell lung cancer were independent risks, confirmed by a sensitivity analysis. Conclusion: Days alive and out of hospital within 90 days after enhanced recovery thoracoscopic wedge resection was only reduced by a median of 2 days, mainly due to air leak and pain.

U2 - 10.1093/bjsopen/zrad144

DO - 10.1093/bjsopen/zrad144

M3 - Journal article

C2 - 38108464

AN - SCOPUS:85180571996

VL - 7

JO - BJS open

JF - BJS open

SN - 2474-9842

IS - 6

M1 - zrad144

ER -

ID: 388018654